1. Home
  2. WVE vs EVC Comparison

WVE vs EVC Comparison

Compare WVE & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

BUY

Current Price

$3.45

Market Cap

744.8M

Sector

Health Care

ML Signal

BUY

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$6.81

Market Cap

683.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
EVC
Founded
2012
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
683.9M
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
WVE
EVC
Price
$3.45
$6.81
Analyst Decision
Strong Buy
Analyst Count
19
0
Target Price
★ $18.06
N/A
AVG Volume (30 Days)
★ 2.9M
1.2M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 2.95%
EPS Growth
N/A
★ 47.59
EPS
N/A
★ 0.32
Revenue
$3,704,000.00
★ $536,034,000.00
Revenue This Year
$19.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$21.25
Revenue Growth
★ 149.43
N/A
52 Week Low
$3.43
$1.95
52 Week High
$21.73
$13.74

Technical Indicators

Market Signals
Indicator
WVE
EVC
Relative Strength Index (RSI) 25.92 25.65
Support Level N/A $2.89
Resistance Level $6.33 $10.09
Average True Range (ATR) 0.23 0.31
MACD -0.02 -0.05
Stochastic Oscillator 8.56 16.05

Price Performance

Historical Comparison
WVE
EVC

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: